vs

Side-by-side financial comparison of OCULAR THERAPEUTIX, INC (OCUL) and Spire Global, Inc. (SPIR). Click either name above to swap in a different company.

Spire Global, Inc. is the larger business by last-quarter revenue ($15.8M vs $13.3M, roughly 1.2× OCULAR THERAPEUTIX, INC). Spire Global, Inc. runs the higher net margin — -176.6% vs -488.0%, a 311.3% gap on every dollar of revenue. On growth, OCULAR THERAPEUTIX, INC posted the faster year-over-year revenue change (-22.4% vs -26.9%). Spire Global, Inc. produced more free cash flow last quarter ($-16.2M vs $-57.1M). Over the past eight quarters, OCULAR THERAPEUTIX, INC's revenue compounded faster (-5.3% CAGR vs -32.6%).

Ocular Therapeutix, Inc. is a biopharmaceutical firm specializing in developing and commercializing innovative ophthalmic therapies. Its products treat acute and chronic eye conditions including post-surgical pain, glaucoma, and dry eye, serving patients and ophthalmology providers primarily across the U.S. and select global markets.

Spire Global, Inc. is a space-to-cloud data and analytics company that specializes in the tracking of global data sets powered by a large constellation of nanosatellites, such as the tracking of maritime, aviation and weather patterns.

OCUL vs SPIR — Head-to-Head

Bigger by revenue
SPIR
SPIR
1.2× larger
SPIR
$15.8M
$13.3M
OCUL
Growing faster (revenue YoY)
OCUL
OCUL
+4.5% gap
OCUL
-22.4%
-26.9%
SPIR
Higher net margin
SPIR
SPIR
311.3% more per $
SPIR
-176.6%
-488.0%
OCUL
More free cash flow
SPIR
SPIR
$40.9M more FCF
SPIR
$-16.2M
$-57.1M
OCUL
Faster 2-yr revenue CAGR
OCUL
OCUL
Annualised
OCUL
-5.3%
-32.6%
SPIR

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
OCUL
OCUL
SPIR
SPIR
Revenue
$13.3M
$15.8M
Net Profit
$-64.7M
$-28.0M
Gross Margin
88.0%
40.2%
Operating Margin
-526.5%
-164.1%
Net Margin
-488.0%
-176.6%
Revenue YoY
-22.4%
-26.9%
Net Profit YoY
-33.6%
42.7%
EPS (diluted)
$-0.27
$-0.85

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
OCUL
OCUL
SPIR
SPIR
Q4 25
$13.3M
$15.8M
Q3 25
$14.5M
$12.7M
Q2 25
$13.5M
$19.2M
Q1 25
$10.7M
$23.9M
Q4 24
$17.1M
$21.7M
Q3 24
$15.4M
$28.6M
Q2 24
$16.4M
$25.4M
Q1 24
$14.8M
$34.8M
Net Profit
OCUL
OCUL
SPIR
SPIR
Q4 25
$-64.7M
$-28.0M
Q3 25
$-69.4M
$-19.7M
Q2 25
$-67.8M
$119.6M
Q1 25
$-64.1M
$-20.7M
Q4 24
$-48.4M
$-48.8M
Q3 24
$-36.5M
$-12.5M
Q2 24
$-43.8M
$-16.6M
Q1 24
$-64.8M
$-25.5M
Gross Margin
OCUL
OCUL
SPIR
SPIR
Q4 25
88.0%
40.2%
Q3 25
87.8%
36.6%
Q2 25
85.6%
48.9%
Q1 25
88.2%
36.8%
Q4 24
92.8%
32.4%
Q3 24
89.9%
44.5%
Q2 24
90.8%
43.0%
Q1 24
91.0%
26.5%
Operating Margin
OCUL
OCUL
SPIR
SPIR
Q4 25
-526.5%
-164.1%
Q3 25
-472.3%
-166.1%
Q2 25
-502.6%
-122.7%
Q1 25
-597.5%
-106.5%
Q4 24
-296.1%
-144.1%
Q3 24
-298.2%
-48.0%
Q2 24
-265.1%
-48.6%
Q1 24
-214.0%
-34.4%
Net Margin
OCUL
OCUL
SPIR
SPIR
Q4 25
-488.0%
-176.6%
Q3 25
-477.3%
-155.3%
Q2 25
-503.9%
623.4%
Q1 25
-598.7%
-86.5%
Q4 24
-283.3%
-225.2%
Q3 24
-236.6%
-43.7%
Q2 24
-266.3%
-65.2%
Q1 24
-438.9%
-73.3%
EPS (diluted)
OCUL
OCUL
SPIR
SPIR
Q4 25
$-0.27
$-0.85
Q3 25
$-0.38
$-0.61
Q2 25
$-0.39
$3.72
Q1 25
$-0.38
$-0.77
Q4 24
$-0.25
$-1.93
Q3 24
$-0.22
$-0.50
Q2 24
$-0.26
$-0.68
Q1 24
$-0.49
$-1.17

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
OCUL
OCUL
SPIR
SPIR
Cash + ST InvestmentsLiquidity on hand
$737.1M
$81.8M
Total DebtLower is stronger
Stockholders' EquityBook value
$654.3M
$112.9M
Total Assets
$808.1M
$211.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
OCUL
OCUL
SPIR
SPIR
Q4 25
$737.1M
$81.8M
Q3 25
$344.8M
$96.8M
Q2 25
$391.1M
$117.6M
Q1 25
$349.7M
$35.9M
Q4 24
$392.1M
$19.2M
Q3 24
$427.2M
$36.6M
Q2 24
$459.7M
$45.8M
Q1 24
$482.9M
$63.7M
Total Debt
OCUL
OCUL
SPIR
SPIR
Q4 25
Q3 25
Q2 25
Q1 25
$103.7M
Q4 24
$103.1M
Q3 24
$4.9M
Q2 24
$4.9M
Q1 24
$123.1M
Stockholders' Equity
OCUL
OCUL
SPIR
SPIR
Q4 25
$654.3M
$112.9M
Q3 25
$258.2M
$133.1M
Q2 25
$305.9M
$149.2M
Q1 25
$265.9M
$3.7M
Q4 24
$315.3M
$-11.7M
Q3 24
$352.0M
$30.8M
Q2 24
$377.7M
$40.3M
Q1 24
$408.0M
$52.5M
Total Assets
OCUL
OCUL
SPIR
SPIR
Q4 25
$808.1M
$211.0M
Q3 25
$410.9M
$224.3M
Q2 25
$451.3M
$239.5M
Q1 25
$405.9M
$208.8M
Q4 24
$457.9M
$193.6M
Q3 24
$490.4M
$224.2M
Q2 24
$517.1M
$230.8M
Q1 24
$538.9M
$252.3M
Debt / Equity
OCUL
OCUL
SPIR
SPIR
Q4 25
Q3 25
Q2 25
Q1 25
27.92×
Q4 24
Q3 24
0.16×
Q2 24
0.12×
Q1 24
2.35×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
OCUL
OCUL
SPIR
SPIR
Operating Cash FlowLast quarter
$-54.2M
$-4.3M
Free Cash FlowOCF − Capex
$-57.1M
$-16.2M
FCF MarginFCF / Revenue
-430.9%
-102.1%
Capex IntensityCapex / Revenue
21.4%
75.1%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-216.9M
$-92.6M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
OCUL
OCUL
SPIR
SPIR
Q4 25
$-54.2M
$-4.3M
Q3 25
$-50.7M
$-12.0M
Q2 25
$-55.2M
$-35.1M
Q1 25
$-44.7M
$-8.4M
Q4 24
$-39.4M
$-19.2M
Q3 24
$-36.6M
$14.0M
Q2 24
$-24.8M
$-4.4M
Q1 24
$-33.9M
$-8.8M
Free Cash Flow
OCUL
OCUL
SPIR
SPIR
Q4 25
$-57.1M
$-16.2M
Q3 25
$-56.7M
$-20.4M
Q2 25
$-56.5M
$-38.7M
Q1 25
$-46.6M
$-17.3M
Q4 24
$-39.6M
$-24.3M
Q3 24
$-36.6M
$5.1M
Q2 24
$-25.5M
$-9.9M
Q1 24
$-34.1M
$-15.9M
FCF Margin
OCUL
OCUL
SPIR
SPIR
Q4 25
-430.9%
-102.1%
Q3 25
-390.0%
-161.3%
Q2 25
-419.7%
-201.7%
Q1 25
-435.6%
-72.6%
Q4 24
-232.0%
-112.2%
Q3 24
-237.6%
17.8%
Q2 24
-155.4%
-39.0%
Q1 24
-231.1%
-45.7%
Capex Intensity
OCUL
OCUL
SPIR
SPIR
Q4 25
21.4%
75.1%
Q3 25
41.2%
66.2%
Q2 25
9.3%
18.8%
Q1 25
18.1%
37.3%
Q4 24
1.2%
23.5%
Q3 24
0.6%
31.2%
Q2 24
4.5%
21.8%
Q1 24
1.7%
20.3%
Cash Conversion
OCUL
OCUL
SPIR
SPIR
Q4 25
Q3 25
Q2 25
-0.29×
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons